• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Medical Economics COVID-19 Survey of 500 US PCPs

Slideshow

The most recent responses from primary care physicians to the hard questions about patients and practice (Survey May 6-12, 2020).

slideshow image
Related Videos
The "Ugly Face" of Long COVID: A Conversation with Steven Flanagan, MD, President-elect, AAPM&R
The "Ugly Face" of Long COVID: A Conversation with Steven Flanagan, MD, President-elect, AAPM&R
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
"Vaccination is More of a Marathon than a Sprint"
"Vaccination is More of a Marathon than a Sprint, so Keep Listening”
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Booster Fatigue, Vaccines are for Kids, and Other Obstacles to Adult Immunization in Primary Care
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro
Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro
Fostering Wellbeing in School-aged Children during COVID-19
Fostering Wellbeing in School-aged Children during COVID-19
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
COVID Sequelae and Primary Care: An Interview with Author Samoon Ahmad, MD
Samoon Ahmad, MD, Discusses His New Book, "Coping with COVID-19: The Mental, Medical, and Social Consequences of the Pandemic"
Samoon Ahmad, MD, Discusses His New Book, "Coping with COVID-19: The Mental, Medical, and Social Consequences of the Pandemic"
COVID-19 is a Cruel Reminder that Obesity IS a Disease, says Thought Leader Donna Ryan, MD
COVID-19 is a Cruel Reminder that Obesity IS a Disease, says Thought Leader Donna Ryan, MD
Related Content
FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years

FDA Grants Full Approval of Moderna’s COVID-19 Vaccine for High-Risk Children Aged 6 Months to 11 Years

Sydney Jennings
July 10th 2025
Article

Moderna’s Spikevax receives full FDA approval for use in children at increased risk for COVID-19, expanding protection ahead of the 2025–2026 virus season.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Image courtesy of Cincinnati Children's

Intranasal COVID-19 Vaccine Found Safe and Immunogenic in Open Label Phase 1 Clinical Trial

Grace Halsey
July 7th 2025
Article

Among recipients of high-dose CVXGA, relative vaccine effectiveness was 67.8% against symptomatic COVID infection at a median 7.3 months post-vaccination.

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Sydney Jennings
October 25th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.

Kennedy's First Pass at US Vaccine Policy: ACIP Guidance Reversed, Clinical Trials Amended, WHO Abandoned / image credit ©Rafael Henrique/stock.adobe.com

Kennedy's First Pass at US Vaccine Policy: ACIP Guidance Reversed, Clinical Trials Amended, WHO Abandoned

Grace Halsey
June 2nd 2025
Article

Kennedy over 2 weeks has introduced changes in vaccination recommendations and research policy that undermine already tenuous public trust and understanding.

FDA Advisory Panel Recommends Continued Use of Monovalent JN.1 Strain for COVID-19 Vaccines / Image credit: ©Tada Images/AdobeStock

FDA Advisory Panel Recommends Continued Use of Monovalent JN.1 Strain for COVID-19 Vaccines

Sydney Jennings
May 27th 2025
Article

FDA panel endorses continued use of monovalent JN.1 strain for COVID-19 vaccines, aligning with global health recommendations amid evolving variants.

© 2025 MJH Life Sciences

All rights reserved.